Skip to content

Drug interactions

Idarubicin + Lonafarnib

Severity: Minor

Idarubicin and Lonafarnib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lonafarnib is a weak P-glycoprotein inhibitor and may slightly increase idarubicin exposure. The clinical effect is probably small but idarubicin has a narrow therapeutic margin.

What this interaction means in plain words

Idarubicin and Lonafarnib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Idarubicin belongs to Oncology; Lonafarnib belongs to Miscellaneous.

Evidence level: Low

Why it happens

Lonafarnib weakly inhibits P-glycoprotein efflux of idarubicin.

What to do

Monitor blood counts and for signs of anthracycline toxicity. Reduce the idarubicin dose if adverse effects develop.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Idarubicin and Lonafarnib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Idarubicin with Lonafarnib?

MediHelp rates the interaction as minor. Idarubicin and Lonafarnib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lonafarnib is a weak P-glycoprotein inhibitor and may slightly increase idarubicin exposure. The clinical effect is probably small but idarubicin has a narrow therapeutic margin.

How serious is the interaction between Idarubicin and Lonafarnib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and for signs of anthracycline toxicity. Reduce the idarubicin dose if adverse effects develop.

What other medicines interact with Idarubicin?

MediHelp also lists interactions of Idarubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cyclophosphamide. The full list is on the Idarubicin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in